Comprehensive assessment of tissue and serum parameters of bone metabolism in a series of orthopaedic patients
Authors:
Open Access
- 27 December 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (12) , e0227133
Abstract
Bone diseases represent an increasing health burden worldwide, and basic research remains necessary to better understand the complexity of these pathologies and to improve and expand existing prevention and treatment approaches. In the present study, 216 bone samples from the caput femoris and collum femoris of 108 patients with degenerative or dysplastic coxarthrosis, hip fracture, or osteonecrosis were evaluated for the proportion of trabecular bone (TB) and expression of parathyroid hormone (PTH) type 1 receptor (PTH1R), osteoprotegerin (OPG), and receptor activator of nuclear factor kappa-B ligand (RANKL). Serum levels of PTH, OPG, soluble RANKL (sRANKL), alkaline phosphatase (AP), osteocalcin, total procollagen type-1 intact N-terminal propeptide (TP1NP), tartrate-resistant acid phosphatase type 5b (TRAP5b), sclerostin, and C-telopeptide of type-1 collagen (ICTP) were also determined. Age was positively correlated with serum levels of PTH, OPG, and sclerostin but negatively associated with TB and sRANKL. Women exhibited less TB, lower sclerostin and ICTP, and higher TRAP5b. Impaired kidney function was associated with shorter bone decalcification time, less TB, lower sRANKL, and higher serum PTH, OPG, and sclerostin. Furthermore, correlations were observed between bone PTH1R and OPG expression and between serum PTH, OPG, and AP. There were also positive correlations between serum OPG and TP1NP; serum OPG and sclerostin; serum AP, osteocalcin, and TRAP5b; and serum sclerostin and ICTP. Serum OPG was negatively associated with sRANKL. In summary, clear relationships between specific bone metabolism markers were observed, and distinct influences of age, sex, and kidney function, thus underscoring their suitability as diagnostic or prognostic markers.Keywords
This publication has 82 references indexed in Scilit:
- Determinants of serum sclerostin in healthy pre- and postmenopausal womenJournal of Bone and Mineral Research, 2011
- PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodelingJournal of Bone and Mineral Research, 2010
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and menJournal of Bone and Mineral Research, 2010
- Biochemical Markers of Bone Turnover, Hip Bone Loss, and Fracture in Older Men: The MrOS StudyJournal of Bone and Mineral Research, 2009
- Relationships among serum receptor of nuclear factor-κB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineraldensity in postmenopausal womenMenopause, 2009
- Osteoprotegerin, vascular calcification and atherosclerosisAtherosclerosis, 2009
- Increased Plasma Osteoprotegerin Concentrations Are Associated with Indices of Bone Strength of the HipThe Journal of Clinical Endocrinology & Metabolism, 2008
- Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic malesArthritis Research & Therapy, 2008
- The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal womenOsteoporosis International, 2005
- Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the ratJournal of Molecular Histology, 2005